(Q41001294)

25 September 2017

title

Malignant ascites: a 2-year review from a teaching hospital (English)

1 reference

25 September 2017

Parsons SL

1

1 reference

25 September 2017

Lang MW

series ordinal

2

1 reference

25 September 2017

Steele RJ

series ordinal

3

1 reference

25 September 2017

publication date

1 June 1996

1 reference

European Journal of Surgical Oncology

25 September 2017

published in

1 reference

25 September 2017

volume

22

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

237-239

1 reference

Care of patients with ascites

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

On the treatment and prognosis of malignant ascites: is the survival time determined when the abdominal paracentesis is needed?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

Malignant ascites. Clinical and experimental observations

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

Malignant ascites of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

Common epithelial cancer of the ovary (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

1 reference

7 January 2021

Intracavitary administration of radioactive isotopes in the control of effusions due to cancer:Results in 267 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

Intracavitary chromic phosphate (32p) colloidal suspension therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2980009-6

7 January 2021

10.1016/S0748-7983(96)80009-6

Identifiers

DOI

1 reference

25 September 2017

1 reference